Internal Medicine Board Review - DiscWrite CD Promotions

CML – treatment
For the Boards
• Allogeneic bone marrow transplant within two
years of diagnosis or – interferon is not used
after the introduction of Gleevec
• Busulfan and hydroxyurea play a role in
reducing blood counts but are palliative and not
curative
• BMT during remission is the only proven
curative i therapy h ffor patients i not responding di to
Gleevec or became resistant